IV Methylprednisolone Does Not Significantly Affect Length Of Hospitalization Vs IV Immunoglobulin Therapy In Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2, Trial Indicates

February 28, 2023

Infectious Disease Advisor (2/27, Barowski) reports, “Children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) who are treated with intravenous (IV) methylprednisolone do not have a statistically significan...